Google TrendARSENAL (5000+) — Arsenal v Lille: Champions League – live
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Eplerenone, a Selective A" (30 stories)

Top Headline Story

Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction
Lead StoryNEJMworld
Jan 27

Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction

<a href="https://news.google.com/rss/articles/CBMiXkFVX3lxTE9QOVNkaGlESnRDakJlX1VnNHNNeVN5MGFzSjBlZFFSWGxhR1pPUjBsVVVxR2d0Y3loVnpqSGlaSm5kM1AzSXFJUGlhd2NjdkduUi1ENGZZQU8xN0NtZ1E?oc=5" target="_blank">Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction</a>  <font color="#6f6f6f">NEJM</font>

Real-time search volume
5000+19m ago

arsenal

Arsenal v Lille: Champions League – live

500+19m ago

anthony gordon

Anthony Gordon's first Barcelona goal, Manuel Neuer's mistake and Djed Spence's Inter debut in the Euro Debrief

2000+29m ago

montez sweat

Bears DE Montez Sweat suspended two games for violating NFL's PED policy

1000+39m ago

rob lowe

Ben Shapiro’s Star-Studded ‘Confession’ Film Includes James Franco, Rob Lowe And More

Search Results for "Eplerenone, a Selective A"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
Aldosterone synthase inhibitors: a new option for antihypertensive, cardio-renal protection
Naturegeneral

Aldosterone synthase inhibitors: a new option for antihypertensive, cardio-renal protection

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1tbUNLUmgyczFEN3hlX2ZCXzdhZks2d2lfSGtqeTVEVkVBRVUtUWt4ZWdGYzhYV1NCTmdMaWtxUUxGTF9jQjhjSWo5YlpOUVpsQ1RkM2NFdzRRZFFYNUdz?oc=5" target="_blank">Aldosterone synthase inhibitors: a new option for antihypertensive, cardio-renal protection</a>  <font color="#6f6f6f">Nature</font>

Oral Eplerenone for Exudative Retinal Detachment Secondary to Central Serous Chorioretinopathy: A Case Report
Cureusgeneral

Oral Eplerenone for Exudative Retinal Detachment Secondary to Central Serous Chorioretinopathy: A Case Report

<a href="https://news.google.com/rss/articles/CBMi4AFBVV95cUxPbGw1X05ZblhQVXRrQzJuckVZbDlKbnZUdHQ0S0Y4bzhQdkdrWkNaUEc1VU16RXJnRFducUkxOHlkSk5XamNRYVdJb0lWcW5WTkV2bVg0UlpIbVdJanIyeGlYS19MckRWeU1fa1ZkM1FLU2RWMFFTbVhoSW1Nc1AzcHM2Y2x2VzN1Z0JIRHdPanNqdUw4VWJpV1NhYTJUOC0tTXJMSmg0dV85czgtVXVET0RsS05yZlp1N1g5Vk5TYnVseEFndDZXQWhGSkpva2tmczY4OHlBX2pKZnRTVWt0UA?oc=5" target="_blank">Oral Eplerenone for Exudative Retinal Detachment Secondary to Central Serous Chorioretinopathy: A Case Report</a>  <font color="#6f6f6f">Cureus</font>

Effects of the Selective Aldosterone Blocker Eplerenone Versus the Calcium Antagonist Amlodipine in Systolic Hypertension
American Heart Association Journalsgeneral

Effects of the Selective Aldosterone Blocker Eplerenone Versus the Calcium Antagonist Amlodipine in Systolic Hypertension

<a href="https://news.google.com/rss/articles/CBMidEFVX3lxTFBKSkhlQ1QwUXEtdHlIaGxJREZveHBwa1VfRC1qbW9TV0JXeGNaWXZ6S2ZyYUR2LURjMS11cG94ckZvbUVvTW9DWVhKUkZoQUF1Q1c2OGhrSjkzTlhMdWdJUks3U0lja3BESXBRSk5vblRWOVpN?oc=5" target="_blank">Effects of the Selective Aldosterone Blocker Eplerenone Versus the Calcium Antagonist Amlodipine in Systolic Hypertension</a>  <font color="#6f6f6f">American Heart Association Journals</font>

Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease
Frontiersgeneral

Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease

<a href="https://news.google.com/rss/articles/CBMikwFBVV95cUxQSnRFaXRXQ01YNEpBZTZKZ1FwWXlvU2k0UFlsdGVHZGg0TXB4T29CaVBMbG9wa1lpVWNWUVlhZ0tpLWVyckZvTFh1dGh3MV9kaDJaUG15aHRpTVVrUVdtOGNLOTVmbGdfQUVZNDNzVnliZHhBLVV4cl9lY0lrSGZpaGxZbkMxWmpHT2JhdjFxSy0td28?oc=5" target="_blank">Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease</a>  <font color="#6f6f6f">Frontiers</font>

Eplerenone and new‐onset diabetes in patients with mild heart failure: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS‐HF) - Preiss - 2012 - European Journal of Heart Failure
Wiley Online Librarytech

Eplerenone and new‐onset diabetes in patients with mild heart failure: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS‐HF) - Preiss - 2012 - European Journal of Heart Failure

<a href="https://news.google.com/rss/articles/CBMib0FVX3lxTE5HNFNnOWtoSHRnQTlQT1NLQUJZc0dhTGg5UlJmdUw2RmZFTDVESmZUT1Yyc0U0Zk82N3lndXhPOW8wNzdiMWpuTGxONGFYYkNObWJmVldXdGFCcWd6MjRTWFVZN2lKR1NWd1cwbFdUZw?oc=5" target="_blank">Eplerenone and new‐onset diabetes in patients with mild heart failure: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS‐HF) - Preiss - 2012 - European Journal of Heart Failure</a>  <font color="#6f6f6f">Wiley Online Library</font>

Eplerenone:
American Heart Association Journalsgeneral

Eplerenone:

<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxOLUgwX3R5RzdaLTlUMXhhYkxDRW44WHpsUHNLZnVJem1yUU5iT1g2ZFZZYW5HMGlHRk1zVEF0LVZWdThzQUFUeE9sQUE2d3lPOHJLM3ZhenpaSlVlcjRIWE9uNlJaSUpBeHpRSnlZbjJjV1A4VWtLVUE1a2hEYzhkLWNzTzVaZ3ZEZlRpcUxMWG9jdUt0NXJBeU9vbWo4VE5CX093VGw5aWw?oc=5" target="_blank">Eplerenone:</a>  <font color="#6f6f6f">American Heart Association Journals</font>

Effects of eplerenone, a selective mineralocorticoid receptor antagonist, on clinical and experimental salt-sensitive hypertension
Naturegeneral

Effects of eplerenone, a selective mineralocorticoid receptor antagonist, on clinical and experimental salt-sensitive hypertension

<a href="https://news.google.com/rss/articles/CBMiUkFVX3lxTE1vanV5YjZ6aHZQZVFZN01SdTh2aFBsQ0drWENtQUViRS1fUnJpb25Bb0pLeFQ5SExsbmluLWdpc0VMTkUtamZSWWRUYlJ4ZUd3N1E?oc=5" target="_blank">Effects of eplerenone, a selective mineralocorticoid receptor antagonist, on clinical and experimental salt-sensitive hypertension</a>  <font color="#6f6f6f">Nature</font>

Metabolite Profiling of Malaysian Gracilaria edulis Reveals Eplerenone as Novel Antibacterial Compound for Drug Repurposing Against MDR Bacteria
Frontierstech

Metabolite Profiling of Malaysian Gracilaria edulis Reveals Eplerenone as Novel Antibacterial Compound for Drug Repurposing Against MDR Bacteria

<a href="https://news.google.com/rss/articles/CBMikwFBVV95cUxQZHZnbnRENWRxYlhSenVQR1cyVTEzOXNHUTdMa0pKVTJpTGVQeklveWl4VDFOWmh3XzNmcnMwaWI5N3hCbHVmOVg1Z0s5dDNvTzVGOHpQMHY2WEtEWU1TNjBzblkyT2tKWUkzSnJpQTlLWFZRRFZvalNrQXZOUTlQWFhya1E1WGRFOEJNLTE1Nk91S2M?oc=5" target="_blank">Metabolite Profiling of Malaysian Gracilaria edulis Reveals Eplerenone as Novel Antibacterial Compound for Drug Repurposing Against MDR Bacteria</a>  <font color="#6f6f6f">Frontiers</font>

Eplerenone in Patients With Acute Myocardial Infarction Complicated by Heart Failure
American Heart Association Journalstech

Eplerenone in Patients With Acute Myocardial Infarction Complicated by Heart Failure

<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxNYk0zdkdRSjMxejJpN1UzRWpZVlROWUFFMXgyMVV1ZlNsd2dpbWdzU0hwVmZxQVBxZmtOY1Y3UDBSSWFNbkpDaTU2TWJVaG1IUDJxSHhkQnFZOEZBY0FFcFZTYThOa09qSzhMZGg1ZnBxQkVvbW5rdnlKanBfTDFlUVFaUjJEM2N6MlVCY1NqZUpOQ0xOV2UtemRueURNcmgzS0NWSXFPdXk?oc=5" target="_blank">Eplerenone in Patients With Acute Myocardial Infarction Complicated by Heart Failure</a>  <font color="#6f6f6f">American Heart Association Journals</font>

Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
NEJMtech

Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms

<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTFBIYmhmRmlPaVlDcEFHV2JDaXUtNWFtMENMUUU3NmFRUTVvXzVIcjBWVmQydDVfekxkaFM3QTJuOUkyVldPTUJoWFRSU0xHc3owXzVyNEVaMURlSUxzVkNEdg?oc=5" target="_blank">Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms</a>  <font color="#6f6f6f">NEJM</font>

Clinical effects of eplerenone, a selective aldosterone blocker, in Japanese patients with essential hypertension
Naturegeneral

Clinical effects of eplerenone, a selective aldosterone blocker, in Japanese patients with essential hypertension

<a href="https://news.google.com/rss/articles/CBMiU0FVX3lxTE9tT1lwVXp0a0lyQnRsa3piNFFIQ3pzTE54Z2RHWkZXSXJjNVlLa1BqcEpsX1ByUkRObFkySmk0YUp0VEtQYVdKVTNjSGtPbG5lZHBR?oc=5" target="_blank">Clinical effects of eplerenone, a selective aldosterone blocker, in Japanese patients with essential hypertension</a>  <font color="#6f6f6f">Nature</font>

Efficacy of Eplerenone Added to Renin-Angiotensin Blockade in Hypertensive Patients
American Heart Association Journalsgeneral

Efficacy of Eplerenone Added to Renin-Angiotensin Blockade in Hypertensive Patients

<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxQM0NFV1c1YVJJU2ZoZW9HU0hvdVVNX2xQNFZjQ29GeUVCMWVJTERxSGpMeGJ3X0xJN1JvdTJxd1oyNlM4a3psbEJCaklQejREVFgzWHVzc0lBeE1sdzRzdmJOeGc3X0JXTEZBekVQQ2d6VnhHWHBfeDR5VHJ0Y3IwVDFxWmdZOFFOekxRcnNBRjUxS0dSVzhyQUZmUFJidDVDQkRoNnF2SEk?oc=5" target="_blank">Efficacy of Eplerenone Added to Renin-Angiotensin Blockade in Hypertensive Patients</a>  <font color="#6f6f6f">American Heart Association Journals</font>

Postpartum administration of eplerenone to mitigate vascular dysfunction in mice following a preeclampsia-like pregnancy | Scientific Reports
Natureworld

Postpartum administration of eplerenone to mitigate vascular dysfunction in mice following a preeclampsia-like pregnancy | Scientific Reports

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBBbkJ1UEFPVktWSWsweU1kR3FIUWI1dWhpWkhEUkZGZXRoY21ZSHRFYXFFMmtacDZmSklnSlZldEhqcUxDYmtsbGFGRk8xc3EydGZMaXBOcGpoQ1BocTdV?oc=5" target="_blank">Postpartum administration of eplerenone to mitigate vascular dysfunction in mice following a preeclampsia-like pregnancy | Scientific Reports</a>  <font color="#6f6f6f">Nature</font>

Double-Blind Randomized Phase 3 Study Comparing Esaxerenone (CS-3150) and Eplerenone in Patients With Essential Hypertension (ESAX-HTN Study)
American Heart Association Journalsgeneral

Double-Blind Randomized Phase 3 Study Comparing Esaxerenone (CS-3150) and Eplerenone in Patients With Essential Hypertension (ESAX-HTN Study)

<a href="https://news.google.com/rss/articles/CBMic0FVX3lxTFAxTE1YNU1FTUREVlBnS3ZWQmpJRnp5TkNhcF9Ja1hTVWpGa0hFM3RXdlJBR3RkU01ObDdXUkZVQXNLbUowdnJiMFRESzl4X3BsNTRHUFZ1VUF4TTNwV1owQy1fbE1CSHlyYXJuektTS1ZEVmM?oc=5" target="_blank">Double-Blind Randomized Phase 3 Study Comparing Esaxerenone (CS-3150) and Eplerenone in Patients With Essential Hypertension (ESAX-HTN Study)</a>  <font color="#6f6f6f">American Heart Association Journals</font>

Comparison of eplerenone and spironolactone for the treatment of primary aldosteronism
Naturegeneral

Comparison of eplerenone and spironolactone for the treatment of primary aldosteronism

<a href="https://news.google.com/rss/articles/CBMiU0FVX3lxTFBxTm42TUh5bzhjR0d5UGJMOWpLRWt1Q0tLUWhhdXV5SVVtZ3l6dXNQUEJ6eHp6eHk5YzhPWFhQNjdFZ1dsa2I1QXZwbUE5ZjRMRS1z?oc=5" target="_blank">Comparison of eplerenone and spironolactone for the treatment of primary aldosteronism</a>  <font color="#6f6f6f">Nature</font>

Eplerenone Inhibits Atherosclerosis in Nonhuman Primates
American Heart Association Journalsgeneral

Eplerenone Inhibits Atherosclerosis in Nonhuman Primates

<a href="https://news.google.com/rss/articles/CBMidEFVX3lxTE1hZHdGR0tsNHkxelIyQ3E0STI2RTRiZ09yMkZxeXUxQ2RNZk4yNmZBbUVUa1ZoS2Z0MWtJcjBTUmZNM2s5Tm9VdGFQWlVBTFlLRTg5RHhzd0wyTC1YbjdHVVpiMWNqYWJEYjJIRlAwR0NJNTl0?oc=5" target="_blank">Eplerenone Inhibits Atherosclerosis in Nonhuman Primates</a>  <font color="#6f6f6f">American Heart Association Journals</font>

Aldosterone Receptor Antagonists:
American Heart Association Journalsgeneral

Aldosterone Receptor Antagonists:

<a href="https://news.google.com/rss/articles/CBMic0FVX3lxTE03NzktMjN5UDdlMkhPWTVpT2ZzSG1Ra3pPd2E5X2ZNZEo2U2ZkZWN1ejBzMUJTQUVHOGxCOTVtY3g0cjFsck1IR0ZHanQtUk5CX2xfOFZzRzd2ZDBwbjkxQ3JCVzZyVU9ZMm5WUFN5VFItTHc?oc=5" target="_blank">Aldosterone Receptor Antagonists:</a>  <font color="#6f6f6f">American Heart Association Journals</font>

Eplerenone restores 24-h blood pressure circadian rhythm and reduces advanced glycation end-products in rhesus macaques with spontaneous hypertensive metabolic syndrome
Naturegeneral

Eplerenone restores 24-h blood pressure circadian rhythm and reduces advanced glycation end-products in rhesus macaques with spontaneous hypertensive metabolic syndrome

<a href="https://news.google.com/rss/articles/CBMiU0FVX3lxTE9pX1BIWks3NWNMX3p0V0J0TjhxeDNxS0RoamZLNFRLeV9Qb1kyOUs3YjRDekl3M3Y5dUt2djM3N3lhc3lQOF9kOXBUc0lNSV9xY0FJ?oc=5" target="_blank">Eplerenone restores 24-h blood pressure circadian rhythm and reduces advanced glycation end-products in rhesus macaques with spontaneous hypertensive metabolic syndrome</a>  <font color="#6f6f6f">Nature</font>

Effects of eplerenone on nephrotic syndrome in a patient with renovascular hypertension
Naturegeneral

Effects of eplerenone on nephrotic syndrome in a patient with renovascular hypertension

<a href="https://news.google.com/rss/articles/CBMiU0FVX3lxTE1kUWRTM3QxTzZmcmpnbkUxZFdNWDFUUzJXOFdoNWVnQWtQcXhFelprSXJLd3g5TXlJUjdBcS05eW9SV0pqWEx4SDNHMGljZHF0T284?oc=5" target="_blank">Effects of eplerenone on nephrotic syndrome in a patient with renovascular hypertension</a>  <font color="#6f6f6f">Nature</font>

Esaxerenone, organ protection without sympathetic activation
Naturegeneral

Esaxerenone, organ protection without sympathetic activation

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1yeVk2RDRNbm14SXptQWpaX0p5VTNfLXA0TGR6aGNjXzdYV25WWlkxbXhUVFI0T3lkU21CN1FjUFJSdXlkc1V5a25LS1UxNjFMcG82M0h6LUV0NjZUQ1FB?oc=5" target="_blank">Esaxerenone, organ protection without sympathetic activation</a>  <font color="#6f6f6f">Nature</font>

Mineralocorticoid Receptor Antagonists Therapy in Resistant Hypertension: Time to Implement Guidelines!
Frontiersgeneral

Mineralocorticoid Receptor Antagonists Therapy in Resistant Hypertension: Time to Implement Guidelines!

<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxNanlvUDA4dDFKdk1DYmRkRXVjZlhWcURkOEpwczFaZ2JibFIzU3g1ZUxsQk5Zb0ZBVDl4YkUzQW9EQzhNU2xzVjFpTDlycXMwMDE0ck5oalhsNlEzSVoxZlFGdXo0RnpzV3FZWGJsSDZsZ1RqVXBSMnVxWmdfVGxQalkzeVpNNGxWbkJ4dFlJelVZV3Nnb2gyM1B2bEFMdFk?oc=5" target="_blank">Mineralocorticoid Receptor Antagonists Therapy in Resistant Hypertension: Time to Implement Guidelines!</a>  <font color="#6f6f6f">Frontiers</font>

Molecular pharmacology of the mineralocorticoid receptor: Prospects for novel therapeutics
ScienceDirect.comgeneral

Molecular pharmacology of the mineralocorticoid receptor: Prospects for novel therapeutics

<a href="https://news.google.com/rss/articles/CBMie0FVX3lxTE1SZGJLcVlyNGsyTUpDRE5yNVRmbU56UldXbkZTTzRqR2RIWUpCNndMckpmdFVDamhTUExPcVlzcTNSWXpJb3VuTEkwaEgwNGZQV1d4QUZtZW9GLU5FQm5XQlR3NmFfOVlmWWtHLXBtODhTWmQydmRMSmFlbw?oc=5" target="_blank">Molecular pharmacology of the mineralocorticoid receptor: Prospects for novel therapeutics</a>  <font color="#6f6f6f">ScienceDirect.com</font>

Selective Mineralocorticoid Receptor Cofactor Modulation as Molecular Basis for Finerenone’s Antifibrotic Activity
American Heart Association Journalsgeneral

Selective Mineralocorticoid Receptor Cofactor Modulation as Molecular Basis for Finerenone’s Antifibrotic Activity

<a href="https://news.google.com/rss/articles/CBMieEFVX3lxTE1sY205QTNrLUNCX3FXYmhkLWNYQmVQVnY5NEo1aFNfdlYxQTZjeEIyTWRHTXg5Y2RrcF8tUWZpaE1zLUhTeVg4NnB1X09xbjBzdkdhTFFQdGtIbkY5X0NJVEh5a24xendDMHF6RTh6MTFOY0U1Zkl3VA?oc=5" target="_blank">Selective Mineralocorticoid Receptor Cofactor Modulation as Molecular Basis for Finerenone’s Antifibrotic Activity</a>  <font color="#6f6f6f">American Heart Association Journals</font>

Cardiac Structure and Function Across the Spectrum of Aldosteronism: the Atherosclerosis Risk in Communities Study
American Heart Association Journalsworld

Cardiac Structure and Function Across the Spectrum of Aldosteronism: the Atherosclerosis Risk in Communities Study

<a href="https://news.google.com/rss/articles/CBMieEFVX3lxTE1HT281SnVOUkVIbE5fanRQQl9LS0lZWkRfc1pPRndYMl81RExZZnpxMFdZQXdWU1VEX0JCYVRjZ255QlZjR2dlVXhzOS1rU1B4M0VyNHdiR2FQUWs4UnJLal9CRGZsYS1VcVFsQ2VWSC1XZzNjanl3eg?oc=5" target="_blank">Cardiac Structure and Function Across the Spectrum of Aldosteronism: the Atherosclerosis Risk in Communities Study</a>  <font color="#6f6f6f">American Heart Association Journals</font>

Baxdrostat for uncontrolled and resistant hypertension: rationale and design of the Phase 3 clinical trials BaxHTN, BaxAsia, and Bax24
Natureworld

Baxdrostat for uncontrolled and resistant hypertension: rationale and design of the Phase 3 clinical trials BaxHTN, BaxAsia, and Bax24

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1tM21CZEh1MXpzbGowcHRXMVlUbXY1ekVaMDRDMGV6Vy1WSXpEaVVKQTNOcGFmbUZ1VnB6MzlUdnNMVVE1WS1GeVBzcTBIbkY0NUU2WGpyVkFOdXFpNVZ3?oc=5" target="_blank">Baxdrostat for uncontrolled and resistant hypertension: rationale and design of the Phase 3 clinical trials BaxHTN, BaxAsia, and Bax24</a>  <font color="#6f6f6f">Nature</font>

Reconsidering the Roles of the Mineralocorticoid Receptor
American Heart Association Journalsgeneral

Reconsidering the Roles of the Mineralocorticoid Receptor

<a href="https://news.google.com/rss/articles/CBMidEFVX3lxTE4zanlYdHBpd2pBUWNkRUNra2ZmT1IwU3lDZ24xTDVudXpEem5INzlpWHV6UWJMUm5tS2VueENGcU9KR09ZeFBEZ2NaQkJOZ01BTEh4VFNEYnFUYWMtdHJRZ0ZndjBOVEpvTGlIMkl2djhWS3U5?oc=5" target="_blank">Reconsidering the Roles of the Mineralocorticoid Receptor</a>  <font color="#6f6f6f">American Heart Association Journals</font>

Immediate Mineralocorticoid Receptor Blockade Improves Myocardial Infarct Healing by Modulation of the Inflammatory Response
American Heart Association Journalsgeneral

Immediate Mineralocorticoid Receptor Blockade Improves Myocardial Infarct Healing by Modulation of the Inflammatory Response

<a href="https://news.google.com/rss/articles/CBMiekFVX3lxTFBXaUdZaTNXYkpld01NQWZ3TzBwcUFXV0xuMzN1U2pHQTFPYTNIRERFYk9XWW9xWEZUSS1ISFpkZUEtS1F0RkJLRjVveGF6RTRMSjRod1VDYTloTHBrM1VmdHVHUkRYTmlJMldTSG9zaXkxMzEzaUQyQUFB?oc=5" target="_blank">Immediate Mineralocorticoid Receptor Blockade Improves Myocardial Infarct Healing by Modulation of the Inflammatory Response</a>  <font color="#6f6f6f">American Heart Association Journals</font>

Role of Aldosterone and Mineralocorticoid Receptor in Cardiovascular Aging
Frontiersgeneral

Role of Aldosterone and Mineralocorticoid Receptor in Cardiovascular Aging

<a href="https://news.google.com/rss/articles/CBMikwFBVV95cUxNM3VNTGFhd09aR1VDTmQ4RDJnZC12RHNoYklMaU9PV0s1ZWt2ZGdPWnNXcGtQQkZwS3QxeWJuTk9mR1NobldUeDA5Y1ZEM1ZqeEdKWnNQQ2lyZWs0RFZuT3ZlUDZOb19aR0Q0UXg3N2JlazI5MGN2Sm9vUkJkeGFBQTRIbDMtcDdDT1FsajZFNWdQczQ?oc=5" target="_blank">Role of Aldosterone and Mineralocorticoid Receptor in Cardiovascular Aging</a>  <font color="#6f6f6f">Frontiers</font>

Optical Coherence Tomography-Based Positive Predictors of Eplerenone Therapy in Chronic Central Serous Chorioretinopathy: A Retrospective Study
Cureusgeneral

Optical Coherence Tomography-Based Positive Predictors of Eplerenone Therapy in Chronic Central Serous Chorioretinopathy: A Retrospective Study

<a href="https://news.google.com/rss/articles/CBMijgJBVV95cUxOd0d4WEthbTc4QjhoNm9NbTlWVG5aRlRiT0FLTEZ4YzBiU2dnV3F3THFmcERmWTM5MnpJMVFwWFMwNzZmc1hjSkJ2M3RJZHZhOVFRalVkMkozYmU0SHpSWTlaUmdrMXVib25HUlhaUXlwdENJeEo2RkJLZmlzYnUzU3FFWlZKd3N3TmdtMW5ESkRGMXYxYW5aNk9SOVYzNE0tR2t1My1kRHExbGZtQjBfWjhyMkVOaVcyU3lmWjZIdk5OWkQ2aVl1SE5tNmlIZXBWeXEzdThUenVpUGFzUjFIMVVvVWpfSElYdUpDZFVNRDZycVVxblQwV21YcG9LaG1zRm01bGRHa0VJYmNPMXc?oc=5" target="_blank">Optical Coherence Tomography-Based Positive Predictors of Eplerenone Therapy in Chronic Central Serous Chorioretinopathy: A Retrospective Study</a>  <font color="#6f6f6f">Cureus</font>

"Eplerenone, a Selective A" — Live Google News Trends & Headlines